Concepedia

Maarten Beekman

MB

14

Publications

411

Citations

12

H-Index

2009

Active since

Affiliations

AstraZeneca (Netherlands)(Current)

AstraZeneca (United Kingdom)

King Abdulaziz University

Kenyatta University

National Taiwan University Hospital

Maarten Beekman is an author at AstraZeneca (Netherlands) specializing in medicine, osteoarthritis, and pharmacology.

ORCID

Top concepts

Publications per year

2009–2022

14

Publications

14

Short-acting β<sub>2</sub>-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

Eric D. Bateman, David Price, Hao‐Chien Wang et al. · European Respiratory Journal · 2021 · 101 citations · Full text

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β<sub>2</sub>-agonist use in asthma

Claudia Cabrera, Cassandra Nan, N Lindarck et al. · European Respiratory Journal · 2019 · 60 citations · Full text

, , +15

Effects of the Cyclooxygenase Inhibiting Nitric Oxide Donator Naproxcinod Versus Naproxen on Systemic Blood Pressure in Patients With Osteoarthritis

William B. White, Thomas J. Schnitzer, Rosanna Fleming et al. · The American Journal of Cardiology · 2009 · 47 citations

, , +4

Efficacy and Safety of Naproxcinod in Patients with Osteoarthritis of the Knee: A 53-Week Prospective Randomized Multicenter Study

Thomas J. Schnitzer, Marc C. Hochberg, Christopher E. Marrero et al. · Seminars in Arthritis and Rheumatism · 2010 · 41 citations

, , +2

Over-prescription of short-acting β <sub>2</sub> -agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Felicia Montero-Arias, Jose Carlos Herrera Garcia, Manuel Pacheco et al. · Journal of Asthma · 2022 · 27 citations

Rows per page

1–5 of 14